No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
HeraMED Ltd. Releases 2024 Corporate Governance Statement
HeraMED Ltd. Reports Revenue Decline and Improved Net Loss for 2024
HeraMED Ltd: Annual Report to shareholders
HeraMED Ltd: Preliminary Final Report
HeraMED Partners With US-Based Smartwatch Provider
HeraMED Ltd. Issues New Unquoted Equity Options